Previous studies have identified PRSS56 and MFRP mutations as a major cause of nanophthalmos, a condition characterized by severe ocular size reduction and extreme hyperopia, suggesting that these factors play a critical role in ocular growth [3–6]. Here, MFRP is linked to hyperopia.